Company: MSTR
Filing Date: 2025-05-22
Form Type: 8-K
Source: 0001193125-25-124568
Chunk: 0

Company: Strategy Inc
Filing Date: 2025-05-22
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01.      Other Events.  

On May 22, 2025, MicroStrategy Incorporated d/b/a Strategy (the “ Company”) entered into a Sales Agreement (the “ Sales Agreement”) with TD Securities (USA) LLC, Barclays Capital Inc., and The Benchmark Company, LLC, as sales agents (each an “ Agent” and collectively, the “ Agents”), pursuant to which the Company may issue and sell shares of its 10.00% Series A Perpetual Strife Preferred Stock, $0.001 par value per share (the “perpetual strife preferred stock”), having an aggregate offering price of up to $2.1 billion (the “ Shares”), from time to time through the Agents (the “ Offering”). Also, on May 22, 2025, the Company filed a prospectus supplement with the Securities and Exchange Commission in connection with the Offering (the “ Prospectus Supplement”) under its existing automatic shelf registration statement, which became effective on January 27, 2025 (File No. 333-284510)(the “ Registration Statement”), and the base prospectus contained therein.

Upon delivery of a placement notice, and subject to the terms and conditions of the Sales Agreement, the Agents may sell the Shares by any method that is deemed an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or any other method permitted by law, which may include negotiated transactions or block trades. The Company may sell the Shares through the Agents in amounts and at times to be determined by the Company from time to time subject to the terms and conditions of the Sales Agreement, but neither it nor the Agents have an obligation to sell any of the Shares in the Offering. No assurance can be given that the Company will sell any Shares under the Sales Agreement, or, if it does, as to the price or amount of Shares that it sells or the dates when such sales will take place. The Company will only sell Shares through one Agent on any single day. Sales pursuant to the Sales Agreement may be made through an affiliate of an Agent.

The Company or the Agents may suspend or terminate the Offering upon notice to the other parties and subject to other conditions. Each Agent will act as sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices.

The Company has agreed to pay the Agents’ commissions for their respective services in acting as agents in the sale of the Shares in the amount of